ŚRODEK PRZECIWDROBNOUSTROJOWY TRICLOSAN   - DZIAŁANIE, ZASTOSOWANIE I ZAGROŻENIA

Magda Izydorczak; Joanna Stefańska

doi:10.56782/pps.57

Published : 2007-08-20

Vol. 5 No. 2 (2007)

ANTIMICROBIAL AGENT TRICLOSAN - ACTIVITY, APPLICATIONS AND HAZARDS

Magda Izydorczak

Joanna Stefańska

DOI: https://doi.org/10.56782/pps.57

Abstract

Triclosan is a synthetic, broad-spectrum antimicrobial agent. It is the substance of choice for hospital hygiene, an ingredient in soaps, deodorants, anti-microbial creams, toothpastes, mouthwashes, and other cosmetics. Many recent studies have demonstrated that overuse of triclosan may promote bacterial resistance to antibiotics.

Keywords:

triclosan, antimicrobial compounds, bacterial resistance

Similar Articles

Sylwia Osowska, Joanna Regulska, Lipid peroxidation markers used in parenteral nutrition , Prospects in Pharmaceutical Sciences: Vol. 21 No. 4 (2023)
Tomasz Pieńko, CAPSAICIN – PROPERTIES, APPLICATIONS TODAY AND FUTURE PROSPECTS , Prospects in Pharmaceutical Sciences: Vol. 11 No. 2 (2013)
Arzu Birinci Yildirim, Ayca Cimen, Yavuz Baba, Arzu Turker, Natural- and in vitro-grown Filipendula ulmaria (L.) Maxim: evaluation of pharmaceutical potential (antibacterial, antioxidant and toxicity) and phenolic profiles , Prospects in Pharmaceutical Sciences: Vol. 22 No. 1 (2024)
Grzegorz Nałęcz-Jawecki, Tomasz Zawadzki, Agata Skrzypczak, SUNSCREENS AND THE ENVIROMENT , Prospects in Pharmaceutical Sciences: Vol. 10 No. 5 (2012)
Agata Pisula, Agnieszka Sienicka, Agnieszka Dobrowolska-Redo, Joanna Kacperczyk-Bartnik, Ewa Romejko-Wolniewicz, PARP inhibitors in ovarian cancer therapy , Prospects in Pharmaceutical Sciences: Vol. 22 No. 2 (2024)
Dominika Winiarz, Kamila Domańska, Kinga Paluch, Dorota Dorota Skrajnowska, PROBIOTICS AND HEALTH - TODAY AND TOMORROW , Prospects in Pharmaceutical Sciences: Vol. 15 No. 10 (2017)
Mateusz Kawka, Maciej Pilarek, Katarzyna Sykłowska-Baranek, Agnieszka Pietrosiuk, ROŚLINNE METABOLITY JAKO KLUCZOWY BIOPRODUKT BIOTECHNOLOGII ROŚLIN , Prospects in Pharmaceutical Sciences: Vol. 15 No. 8 (2017)
Angelika Lis, Katarzyna Wyszomierska, Katarzyna Znajdek, Łukasz Szeleszczuk, Monika Zielińska-Pisklak, PHOTOSENSITIVITY PHENOMENON – A SIGNIFICANT ADVERSE EFFECT OF COMMONLY USED DRUGS , Prospects in Pharmaceutical Sciences: Vol. 19 No. 3 (2021)

<< < 2 3 4 5 6 7

You may also start an advanced similarity search for this article.

Details

References

Statistics

Authors

Download files

PDF (Język Polski)

Citation rules

Izydorczak, M., & Stefańska, J. (2007). ANTIMICROBIAL AGENT TRICLOSAN - ACTIVITY, APPLICATIONS AND HAZARDS. Prospects in Pharmaceutical Sciences, 5(2), 13–17. https://doi.org/10.56782/pps.57

Altmetric indicators

Cited by / Share

Licence

This work is licensed under a Creative Commons Attribution 4.0 International License.

References

Adolfsson-Erici M., Petterson M., Parkkonen J., Sturve J. Triclosan, a commonly used bactericide found in human milk and in the aquatic environment in Sweden. Chemosphere, 2002, 46: 1485-1489 DOI: https://doi.org/10.1016/S0045-6535(01)00255-7

Bhargava H.N., Leonard P. A. Triclosan: applications and safety. Am. J. Infect Control.1996, 24: 209-218 DOI: https://doi.org/10.1016/S0196-6553(96)90017-6

Chuanchuen, R., Beinlich K., Hoang T. T., Becher A., Karkhoff-Schweizer R. R., Schweitzer H. P. Cross-resistance between triclosan and antibiotics in Pseudomonas aeruginosa is mediated by multidrug efflux pumps: exposure of a susceptible mutant strain to triclosan selects nfxB mutants overexpressing MexCD-OprJ. Antimicrob. Agents Chemother. 2001, 45: 428-432 DOI: https://doi.org/10.1128/AAC.45.2.428-432.2001

Ciba speciality Chemicals. Value beyond chemistry. /www.cibasc.com/

Citizen Petition to the U. S. Food and Drug Administration (FDA) to Ban Triclosan. (2005)

Davies J. Inactivation of antibiotics and dissemination of resistance genes. Science 1994, 264: 375-382 DOI: https://doi.org/10.1126/science.8153624

Durbize E., Vigan M., Puzenat E. Spectrum of cross-photosensitization in 18 consecutive patients with contact photoallergy to ketoprofen: associated photoalergies to non-benzophenone-containing microbes. Contact Dermatitis, 2003, 48: 144-149 DOI: https://doi.org/10.1034/j.1600-0536.2003.00066.x

Fan F., Yan K., Wallis N. G., Reed S., Moore T. D., Rittenhouse S. F., DeWolf W. E. Jr., Huang J., McDevitt D., Miller W. H., Seefeld M. A., Newlander K. A., Jakas D. R., Head M. S., Payne D. J. Defining and combating the mechanisms of triclosan resistance in clinical isolates of Staphylococcus aureus. Antimicrob. Agents Chemother. 2002, 46: 3343-3347 DOI: https://doi.org/10.1128/AAC.46.11.3343-3347.2002

FDA. Glossary of Pesticide Chemicals. June 2005

Heath R. J., Li J., Roland G. E., Rock C. O. Inhibition of the Staphylococcus aureus NADPH-dependent enoyl-acyl carrier protein reductase by triclosan and hexachlorophene. J. Biol. Chem. 2000, 275: 4654-4659 DOI: https://doi.org/10.1074/jbc.275.7.4654

Hoang T. T., Schweizer H. P. Characterization of Pseudomonas aeruginosa enoyl-acyl carrier protein reductase (FabI): a target for the antimicrobial triclosan and its role in acylated homoserine lactone synthesis. J. Bacteriol. 1999, 181: 5489-5497 DOI: https://doi.org/10.1128/JB.181.17.5489-5497.1999

Jones R. D., Jampani H. B, Newman J. L., Lee A. S. Triclosan: a review of effectiveness and safety in Heath care settings. Am. J. Infect. Control. 2000, 28: 184-196 DOI: https://doi.org/10.1067/mic.2000.102378

Latch D. E., Packer J. L., Stender B. L., VanOverbeke J., Arnold W. A., McNeil K. Aqueous photochemistry of triclosan: formation of 2,4-dichlorophenol, 2,8-dichlorodibenzo-p-dioxin and oligomerization products. Environ. Toxicol. Chem. 2005, 24: 517-525. DOI: https://doi.org/10.1897/04-243R.1

Levy C. W., Roujeinikovai A., Sedelnikova S., Baker P. J., Stuitje A. R., Slabas A. R., Rice D., Rafferty J. B. Molecular basis of triclosan activity. Nature, 1999, 398: 383-384 DOI: https://doi.org/10.1038/18803

McMurry L. M., McDermott P. F., Levy S. B. Genetic evidence that InhA of Mycobacterium smegmatis is a target for triclosan. Antimicrob. Agents Chemother.1999, 43: 711-713 DOI: https://doi.org/10.1128/AAC.43.3.711

McMurry L. M., Oethinger M., Levy S. B. Triclosan targets lipid synthesis. Nature, 1998, 394: 531-532 DOI: https://doi.org/10.1038/28970

McMurry L. M., Oethinger M., Levy S. B. Overexpression of marA, soxS, or acrAB produces resistance to triclosan in laboratory and clinical strains of Escherichia coli. FEMS Microbiol. Lett. 1998, 166: 305-309 DOI: https://doi.org/10.1111/j.1574-6968.1998.tb13905.x

Meade M. J., Waddell R. J., Callahan T. M. Soil bacteria Pseudomonas putida and Alcaligenes xylosoxidans subsp. denitificans inactivate triclosan in liquid and solid substrates. FEMS Microbiol. Lett. 2001, 204: 45-48 DOI: https://doi.org/10.1111/j.1574-6968.2001.tb10860.x

Miller T. L., Larusso D. J., Walsh M. L,. Deinzer M. L. The acute toxicity of penta-hexa-, and heptachlorohydroxydiphenyl ethers in mice. J. Toxicol. Environ. Heath. 1983, 12: 245-253 DOI: https://doi.org/10.1080/15287398309530423

Perozzo R., Kuo M., Sidhu A. S, Valiyaveettil J. T., Bittman R., Jacobs. W.R. Jr. Fidock D. A, Sacchettini J.C. Structural elucidation of the specificity of the antibacterial agent triclosan for malarial enoyl-acyl carrier protein reductase. J. Biol. Chem. 2002, 277: 13106-13114 DOI: https://doi.org/10.1074/jbc.M112000200

Qiu X., Janson Ch. A, Court R. J., Smyth M. G., Payne D. J., Abel-Meguid S.S. Molecular basis for triclosan activity involves a flipping loop in the active site. Protein Science, 1999, 8: 2529-2532 DOI: https://doi.org/10.1110/ps.8.11.2529

Randall L. P., Ridley A. M., Cooles S. W., Sharma M., Sayers A. R., Pumbwe L., Newell D. G., Piddock L. J., Woodward M.J. Prevalence of multiple antiboitic resistance in 443 Campylobacter spp. isolated from humans and animals. J. Antimicrob. Chemother. 2003, 52: 507-510 DOI: https://doi.org/10.1093/jac/dkg379

Randall L. P., Cooles S. W., Piddock L. J., Woodward M. J. Effect of triclosan or a phenolic farm disinfectant on the selection of antibiotic-resistant Salmonella enterica. J. Antimicrob. Chemother. 2004, 54:621-627. DOI: https://doi.org/10.1093/jac/dkh376

Russell A. D. Whither triclosan? J. Antimicrob. Chemother. 2004, 53: 693-695 DOI: https://doi.org/10.1093/jac/dkh171

Sanchez P., Moreno E., Martinez J. L The biocie triclosan selects Stenotrophomonas maltophilia mutants that overproduce the SmeDEF multidrug efflux pump. Antimicrob. Agents Chemother. 2005, 49: 781-782 DOI: https://doi.org/10.1128/AAC.49.2.781-782.2005

Schmid M.B., Kaplan N. Reduced triclosan susceptibility in methicillin-resistance Staphylococcus epidermidis. Antimicrob. Agents Chemother. 2004, 48: 1397-1399 DOI: https://doi.org/10.1128/AAC.48.4.1397-1399.2004

Suller M. T. E., Russell A. D. Triclosan and antibiotic resistance in Staphylococcus aureus. J. Antimicrob. Chemother. 2000, 46: 11-18 DOI: https://doi.org/10.1093/jac/46.1.11

Wammer K. H., Lapara T. M., McNeil K., Arnold W. A., Swackhamer D. L. Changes in antibacterial activity of triclosan and sulfa drugs due to photochemical transformations. Environ. Toxicol. Chem. 2006, 25: 1480-1486 DOI: https://doi.org/10.1897/05-384R.1

Wilson B. A., Orvos D. R., Versteeg D. J., Inauen J., Capdevielle M. Aquatic toxicity of triclosan. Environ. Toxicol. Chem. 2002, 21: 1338-1349 DOI: https://doi.org/10.1002/etc.5620210703

Yazdankhah, S. P., Scheie A. A., Hoiby E. A., Lunestad B. T, Heir E., Fotland T. O., Naterstad K., Kruse H. Triclosan and antimicrobial resistance in bacteria: an overview. Microb. Drug Resist. 2006,12: 83-90 DOI: https://doi.org/10.1089/mdr.2006.12.83

Magda Izydorczak

Affiliation:

Studenckie Koło Naukowe przy Zakładzie Mikrobiologii Farmaceutycznej Poland

Joanna Stefańska

Affiliation:

Zakład Mikrobiologii Farmaceutycznej Wydział Farmaceutyczny Akademii Medycznej w Warszawie Poland

ANTIMICROBIAL AGENT TRICLOSAN - ACTIVITY, APPLICATIONS AND HAZARDS

Magda Izydorczak

Joanna Stefańska

Abstract

Keywords:

Most read articles by the same author(s)

Similar Articles

Magda Izydorczak

Joanna Stefańska